Last updated on February 2018

Early Non-invasive Detection of CTEPH After Pulmonary Embolism


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Chronic Thromboembolic Pulmonary Hypertension
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • All patients with an objectivated first or recurrent diagnosis of symptomatic acute PE, who have been treated for at least three months with therapeutically dosed anticoagulant therapy according to current guidelines;
  • Signed and dated informed consent of the subject available before the start of any specific study procedures;
  • Age 18 years;

Exclusion criteria:

  • Known CTEPH or PH;
  • Known (i.e. echocardiographic confirmed) NYHA class III or IV chronic heart failure due to left ventricular systolic dysfunction, left ventricular diastolic dysfunction or significant valvular lesions;
  • Severe renal failure (eGFR <15 ml/min) or renal replacement therapy;
  • Medical or psychological condition that would not permit completion of the study or signing of informed consent, including life expectancy less than six months, or unwillingness to sign informed consent;
  • Non-compliance or inability to adhere to treatment or to the follow-up visits.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.